Stocks

US launches may lift Dr Reddy’s Laboratories

| Updated on September 16, 2019 Published on September 17, 2019

 

Dr Reddy’s Laboratories on Monday said it has launched over-the-counter Lansoprazole capsules, used for treatment of frequent heartburn, in the US market.

The company has launched Lansoprazole delayed-release capsules USP in the strength of 15 mg in the US market, as approved by the United States Food and Drug Administration, Dr Reddy’s said in a BSE filing. Last week, Dr Reddy’s had announced the launch of Fosaprepitant for injection in the US.

Published on September 17, 2019
This article is closed for comments.
Please Email the Editor